Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DPP-4 Inhibition and the Path to Clinical Proof
Bo Åhrén
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: a review
Carina Proença, Daniela Ribeiro, Marisa Freitas, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 12, pp. 3137-3207
Closed Access | Times Cited: 141
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
Matthias H. Tschöp, Rubén Nogueiras, Bo Åhrén
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1796-1808
Open Access | Times Cited: 51
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
Ichiro Takada, Makoto Makishima
Expert Opinion on Therapeutic Patents (2019) Vol. 30, Iss. 1, pp. 1-13
Closed Access | Times Cited: 122
Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities
Sara Santa-Cruz Calvo, Leena P. Bharath, Gabriella H. Pugh, et al.
Nature Reviews Endocrinology (2021) Vol. 18, Iss. 1, pp. 23-42
Open Access | Times Cited: 99
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Ruili Yin, Yongsong Xu, Xin Wang, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3055-3055
Open Access | Times Cited: 50
Bioactive Peptide Discovery from Edible Insects for Potential Applications in Human Health and Agriculture
Yixian Quah, Shi-Ruo Tong, Joanna Bojarska, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1233-1233
Open Access | Times Cited: 33
A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications
Fatma Haddad, Ghadeer Dokmak, Maryam Bader, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 33
Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges
Kanghong Hu, Huizhong Huang, Hanluo Li, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 25
Proline Analogues
Vladimir Kubyshkin, Marina Rubini
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8130-8232
Closed Access | Times Cited: 10
Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders
Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112801-112801
Closed Access | Times Cited: 55
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
Allison A. Fitzgerald, Shangzi Wang, Veena R. Agarwal, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e002837-e002837
Open Access | Times Cited: 50
Hempseed (Cannabis sativa) protein hydrolysates: A valuable source of bioactive peptides with pleiotropic health-promoting effects
Guillermo Santos‐Sánchez, Ana Isabel Álvarez‐López, Eduardo Ponce‐España, et al.
Trends in Food Science & Technology (2022) Vol. 127, pp. 303-318
Open Access | Times Cited: 36
Hypoglycemic bioactivity of anthocyanins: A review on proposed targets and potential signaling pathways
Zhiying Li, Jinlong Tian, Zhen Cheng, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 26, pp. 7878-7895
Closed Access | Times Cited: 32
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 31
Effect of enzymatic hydrolysis of pulse protein macromolecules to tailor structure for enhanced nutraceutical properties
Zanoor ul Ashraf, Asima Shah, Asir Gani, et al.
LWT (2024) Vol. 205, pp. 116502-116502
Open Access | Times Cited: 6
Repurposing anti-diabetic drug “Sitagliptin” as a novel virulence attenuating agent in Serratia marcescens
Hisham A. Abbas, Wael A. H. Hegazy
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0231625-e0231625
Open Access | Times Cited: 49
A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure
Ryan P. Ceddia, Sheila Collins
Clinical Science (2020) Vol. 134, Iss. 5, pp. 473-512
Open Access | Times Cited: 46
A comprehensive review on the antidiabetic activity of flavonoids targeting PTP1B and DPP-4: a structure-activity relationship analysis
Carina Proença, Daniela Ribeiro, Marisa Freitas, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 15, pp. 4095-4151
Closed Access | Times Cited: 35
The Function of Gastrointestinal Hormones in Obesity—Implications for the Regulation of Energy Intake
Mona Farhadipour, Inge Depoortere
Nutrients (2021) Vol. 13, Iss. 6, pp. 1839-1839
Open Access | Times Cited: 35
Association of antidiabetic medications with depression risk and All-Cause mortality in type 2 Diabetes: A TriNetX-Based cohort study
I‐Chieh Chen, Yen‐Wei Pai, Jun‐Fu Lin, et al.
Diabetes Research and Clinical Practice (2025), pp. 112167-112167
Open Access
A Review of Dipeptidyl Peptidase-4 (DPP-4) and its potential synthetic derivatives in the management of Diabetes Mellitus

Journal of Angiotherapy (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
Ashley Wang, Savannah Bitzas, D. Perez, et al.
Life (2025) Vol. 15, Iss. 3, pp. 427-427
Open Access
Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors
Leonard Sewald, Werner W. A. Tabak, Lorenz Fehr, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The impact of DPP-4 inhibitors on cardiovascular disease treatment: a comprehensive review of current therapeutic strategies and future directions
Toka Elemary, Mina Nicola, Mohamed E. A. Abdelrahim, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Glucose effectiveness: Lessons from studies on insulin‐independent glucose clearance in mice
Bo Åhrén, Giovanni Pacini
Journal of Diabetes Investigation (2020) Vol. 12, Iss. 5, pp. 675-685
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top